Literature DB >> 11824058

[Early colorectal reoperation: risk factors].

M Amoruso1, D D'Abbicco, A Notarnicola, A Angrisano, M Nacchiero, G Martino Bonomo.   

Abstract

The aim of the study was to analyse the risk factors in colorectal reoperation. Over the period from January 1987 to December 1999, 371 patients (191 male and 180 female, aged from 16 to 88 years) underwent colorectal surgery. Eighteen reoperations (12 male, 6 female, aged from 20 to 74 years; median age: 52.6 years) were performed. These included reoperations performed within 30 days of the first operation (or patient admission). The overall incidence of reoperation after colorectal surgery was 4.8% (18/371). In 14 of 18 patients (77%) anastomotic dehiscence was the indication for reoperation. In our experience, the mortality rate was 16.6% (3/18), in agreement with other reports in the literature. Analysis of risk factors in colorectal reoperation poses several methodological problems because we have no randomized multicentre studies that analyse risk factors in colorectal reoperation and the related surgical mortality.

Entities:  

Mesh:

Year:  2001        PMID: 11824058

Source DB:  PubMed          Journal:  Chir Ital        ISSN: 0009-4773


  2 in total

1.  The integrity of colonic anastomoses following the intraperitoneal administration of oxaliplatin.

Authors:  Konstantinos Blouhos; Manousos-Georgios Pramateftakis; Theodor Tsachalis; Dimitrios Kanellos; Thomas Zaraboukas; Georgios Koliakos; Dimitrios Betsis
Journal:  Int J Colorectal Dis       Date:  2010-03-09       Impact factor: 2.571

2.  Healing of colonic anastomoses after immediate postoperative intraperitoneal administration of oxaliplatin.

Authors:  Dimitrios Kanellos; Manousos-Georgios Pramateftakis; Haralampos Demetriades; Emmanouil Zacharakis; Stamatios Angelopoulos; Ioannis Mantzoros; Ioannis Kanellos; Kalliopi Despoudi; Thomas Zaraboukas; Georgios Koliakos; Kalliopi Galovatsea; Haralampos Lazaridis
Journal:  Int J Colorectal Dis       Date:  2008-08-02       Impact factor: 2.571

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.